Stay updated on Combination Therapy in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Combination Therapy in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Combination Therapy in Relapsed Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.5 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference0.1%
- Check20 days agoChange DetectedThe page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours. The previous mention of the last update posted has been removed.SummaryDifference0.7%
- Check27 days agoChange DetectedThe page has been updated with new information regarding clinical trial data sharing by AbbVie, including a commitment to responsible data sharing and a new link for requests. Additionally, several locations and institutions have been added or updated, while some previous entries have been removed.SummaryDifference6%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check56 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check63 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1.0%
Stay in the know with updates to Combination Therapy in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Therapy in Relapsed Multiple Myeloma Clinical Trial page.